ECSP961798A - SOMATOSTATINE PEPTIDES - Google Patents

SOMATOSTATINE PEPTIDES

Info

Publication number
ECSP961798A
ECSP961798A ECSP961798A ECSP961798A EC SP961798 A ECSP961798 A EC SP961798A EC SP961798 A ECSP961798 A EC SP961798A EC SP961798 A ECSP961798 A EC SP961798A
Authority
EC
Ecuador
Prior art keywords
ala
amino acid
residue
lys
somatostatin
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Rainer Albert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961798 priority Critical patent/ECSP961798A/en
Publication of ECSP961798A publication Critical patent/ECSP961798A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a análogos de somatostatina que comprenden la secuencia de amino ácidos, de la fórmula I, Trp Lys-X1-X2 en donde X1, es un residuo Thr, Ser, Tyr, Glu o Cys, sustituido y X2 es un alfa amino ácido que tiene un residuo aromático en la cadena lateral Calfa, o una unidad de amino ácido seleccionada de Dab, Dpr, Dpm, His, (Bzl)Hypro, tienilo -Ala, ciclohexil -Ala y terbutilo -Ala, el residuo Lys de esa secuencia corresponde al residuo Lys de la somatostatina 14 original, en forma libre, en la forma de sal o formando un complejo con un elemento detectable que tenga propiedades farmacológicas de interes.The present invention relates to somatostatin analogs comprising the amino acid sequence, of the formula I, Trp Lys-X1-X2 where X1 is a substituted Thr, Ser, Tyr, Glu or Cys residue and X2 is a alpha amino acid having an aromatic residue in the Calfa side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His, (Bzl) Hypro, thienyl -Ala, cyclohexyl -Ala and terbutyl -Ala, the Lys residue this sequence corresponds to the Lys residue of the original somatostatin 14, in free form, in the salt form or in a complex with a detectable element that has pharmacological properties of interest.

ECSP961798 1996-06-25 1996-06-25 SOMATOSTATINE PEPTIDES ECSP961798A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961798 ECSP961798A (en) 1996-06-25 1996-06-25 SOMATOSTATINE PEPTIDES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961798 ECSP961798A (en) 1996-06-25 1996-06-25 SOMATOSTATINE PEPTIDES

Publications (1)

Publication Number Publication Date
ECSP961798A true ECSP961798A (en) 1997-11-28

Family

ID=42042528

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961798 ECSP961798A (en) 1996-06-25 1996-06-25 SOMATOSTATINE PEPTIDES

Country Status (1)

Country Link
EC (1) ECSP961798A (en)

Similar Documents

Publication Publication Date Title
MY147327A (en) Somatostatin peptides
DE69629210D1 (en) INSULINABKÖMMLINGE
ATE201696T1 (en) CYCLIC PEPTIDE ANALOGUES OF SOMATOSTATIN
FI961044A0 (en) Kininogeninhibitorer
DK0479912T3 (en) Method for inhibiting the course of N-end rule in living cells
ATE63126T1 (en) TETRA- AND PENTA-PEPTIDES WITH THE SEQUENCE LYSYLARGINYL-ASPARTYL, AND THEIR USE AS ANTITROMBOTICS.
ATE146188T1 (en) SUBSTITUTION ANALOGUES OF MAGAININ PEPTIDES
ATE301714T1 (en) INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN -3 VARIANT
CO4700528A1 (en) SOMATOSTATINE PEPTIDES
ECSP961798A (en) SOMATOSTATINE PEPTIDES
NO20012232L (en) Enzymatic amidation of peptides
DE60326581D1 (en) Labeled peptides having an affinity for a phospholipid and its uses
CO5090903A1 (en) NEW PEPTIDES TO BE USED IN AN Induced TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, Rheumatoid ARTHRITIS
SE9700301D0 (en) New compound